Australian company advances anti-cancer drug
A Melbourne, Australia-based drug manufacturer, Cytopia Limited, is proceeding to the next phases of testing in clinical studies for its anti-cancer compound, CYT997. The vascular disrupting agent...
View ArticleONCONASE on fast track for Meso treatment
SOMERSET, N.J., April 2, 2008 – PRNewswire – Alfacell Corporation today announced that it has confirmed that 316 evaluable events (patient deaths) have occured in the confirmatory Phase IIIb clinical...
View ArticleNew mesothelioma drug being developed
I recently posted about the progress of a new drug to treat mesothelioma, called ONCONASE, which has completed Phase IIIb clinical trials and is being fast-tracked for approval in the U.S. ONCONASE...
View ArticleMesothelioma could kill 10% of Aussie carpenters
A new study is predicting 10 percent of Australian carpenters born before 1950 will die of mesothelioma. The Australian study, conducted by cancer research specialist Professor Julian Peto, was based...
View ArticleAustralia braces for new wave of mesothelioma cases
A report in The Courier Mail, based in Queensland, Australia, says mesothelioma deaths could double in the coming years, as the disease begins to strike end users of asbestos products, like amateur...
View ArticleOnconase fails in primary late-stage trial
Alfacell Corp., a biotechnology company that manufactures Onconase, released a disappointing report Wednesday regaring its Onconase product, which was hoped to be a significant treatment for...
View ArticleQuintessence continues with mesothelioma drug
On April 21 I reported that a Madison, Wisconsin-based biotechnology firm, Quintessence Bioscience, was moving forward on a drug similar to Alfacel’s Onconase, to treat mesothelioma. The report, from...
View ArticleONCONASE expands to Israel as meso concerns there grow
Today Alfacell, the manufacturer of ONCONASE, announced it will begin distribution of the mesothelioma drug in Israel. The company will partner with Megapharm, Ltd., a leading pharmaceutical company in...
View ArticleClik here to view.
Shadwick CD benefits mesothelioma research
Thirty-four years after its original recording, Candid Records has released a jazz CD to honor the memory of noted British journalist and musician Keith Shadwick, with all proceeds from the sale going...
View ArticleClik here to view.
jazz CD a tribute to artist affected by meso
Last week, I mentioned that I’d come across an interesting story about a jazz musician and noted writer in Britain, who released a recording of his work begun in 1973. Keith Shadwick was a professional...
View ArticleClik here to view.
Australia losing expert craftsman to mesothelioma
For generations, skilled craftspeople and artisans have passed down their secrets for creating fine handmade furniture. Among the best is Tom Harrington, of the Southern Highlands area of Australia....
View ArticleMeso survivor delivers ‘miracle baby’ in time for Christmas
About this time last year, Melbourne, Australia, resident Anita Steiner was facing the prospect of terminal cancer. At 45 years old, she had been diagnosed with mesothelioma. Her doctor estimated she...
View ArticleClik here to view.
Australian asbestos fighter Banton honored
Bernie Banton, who was the face of the fight against asbestos in Australia, was honored posthumously Jan. 21 with the opening of the Bernie Banton Centre at Sydney’s Concord Hospital. The centre, which...
View ArticleClik here to view.
James Hardie executives handed penalties in asbestos compensation fund case
The Australian Securities and Investment Commission (ASIC) reported this week that the New South Wales Supreme Court on Thursday ruled that it will impose penalties against seven former directors and...
View ArticleStudy supports extrapleural pneumonectomy to treat select mesothelioma patients
The results of a study published recently in The Journal of Thoracic and Cardiovascular Surgery supports the use of extrapleural pneumonectomy-based multimodal therapy in carefully selected patients...
View ArticleAustralian photographer captures emotions of meso widows in touching exhibit
An Australian artist, photographer Chris Ireland, has created an emotional exhibit titled “Breathe,” which captures the feelings of 14 women who have lost their husbands to mesothelioma and other...
View ArticleClik here to view.
Bionomics set to begin Phase II clinical trial following initial success of...
The Sydney Morning Herald has reported that biotechnology company Bionomics is set to begin a Phase II clinical trial of its anti-cancer drug, BNC105, at up to 12 cancer treatment centers across...
View ArticleClik here to view.
Australian doctor researching radiotherapy for treatment of pleural mesothelioma
One of the many mesothelioma community members on Facebook posted a question today about a clinical trial being conducted at the Mesothelioma Center, located at New York-Presbyterian Hospital. MyMeso...
View ArticleClik here to view.
Bionomics begins Phase II clinical trial of mesothelioma med in Australia
Bionomics, an Australian biotechnology company, has announced the beginning of Phase II clinical trials for its vascular disrupting agent BNC105 as a treatment for mesothelioma. The company announced...
View ArticleClik here to view.
‘Third wave’ of asbestos victims being diagnosed with mesothelioma
In Australia, which has the highest per capital rate of mesothelioma in the world, doctors and researchers are seeing a new wave of younger people diagnosed. They call these patients the “third wave”...
View Article